May is Myositis Awareness Month. Myositis Support and Understanding commemorates the month with patient-centered events

The MSU Myositis Awareness Theme

The MSU Myositis Awareness Theme

MSU Talking points for our Zebra Spots campaign

MSU Talking points for our Zebra Spots campaign

Myositis Support and Understanding Association logo

Myositis Support and Understanding Association, Inc.

Our theme, "With Myositis, Sometimes Zebras Have Spots" refers to the multitude of ways patients lives are affected in every aspect by Inflammatory Myopathies

Myositis is such a difficult and complicated disease that goes beyond just muscle and skin. Living with this disease is difficult and affects every aspect of the patient's life. We are here to help.”

— Jerry Williams, President

LINCOLN, DELAWARE, USA, April 28, 2017 /EINPresswire.com/ — Myositis Support and Understanding Association, a 501(c)3 nonprofit organization, commemorates Myositis Awareness month with our 2017 Theme, “With Myositis, Sometimes Zebras have Spots.”

The zebra is the well-recognized symbol of rare diseases. Myositis, a rare disease without a cure, is often hard to diagnose, taking years for a proper diagnosis, and even more difficult to treat, due to differences in disease markers, overlap symptoms, side effects from medications, etc. MSU has decided to use 2017’s May month of awareness to teach about how the experiences and symptoms of this rare disease are different, even among the patients with the same disease. Doctors are now starting to be trained when you hear hoof beats, look for zebras (rarities), instead of horses (common ailments), when in the past, they only looked for horses (the most common ailments). Through our public education and support of our members, plus our financial assistance program, MSU helps patients deal with the spots of the zebra called Myositis.

Myositis is a term that literally means inflammation of the muscles. The focus of MSU is on the Idiopathic Inflammatory Myopathies of which there are several types, and are all classified as rare diseases. Myositis does not only affect the muscles and skin. It is a systemic disease and can affect many different organ systems.

Polymyositis causes muscle weakness around the middle of the body and affects both sides of the body. Dermatomyositis can cause the same muscle weakness, while for some the muscle weakness never presents. This is referred to as Amyopathic Dermatomyositis. DM also causes skin rashes, however, for darker skinned people, especially of African descent, these rashes can be difficult to see thus leading to a longer period of getting a proper diagnosis. Juvenile Dermatomyositis differs from the adult form because of the coexistence of Vasculitis (inflammation of blood vessels). Inclusion body myositis mainly affects older individuals and as muscle weakness becomes severe, it is accompanied by muscle wasting and diminished deep-tendon reflexes. Unlike Polymyositis and Dermatomyositis, the muscle weakness is often asymmetric and may be prominent in the smaller muscles of the forearms and calves.

No matter which form of Myositis patients may have, getting a proper diagnosis is often years in the making. And, there are multiple potential complications and many patients become disabled due to the weakness and other factors. Education of patients so they can advocate for themselves is key. MSU is here to help.

To raise awareness of this complicated, rare disease, MSU has scheduled many activities to promote awareness and to educate.

• “Sometimes Zebras have Spots” T-shirt Campaign and Talking sheet. We have had our best T-Shirt campaign yet, selling shirts with our awareness theme, a spotted zebra, which will be accompanied by an information sheet giving members talking points about the “spots” of myositis.

• #PutaFacetoMyositis – We’ve invited members to share their own “Spot” stories of a difficult diagnosis, rarity, adaptation, they have made, or side effect of medication to be placed on an interactive Zebra graphic on our website.

• Strategic Plan Survey – MSU is committed to making its actions be a better and better reflection of its members. As such, we are asking our members to speak up and share their voice by participating in our strategic planning by filling out an important survey about our services and platforms, as well as where they would like to see us go in the future. This will further help us #PutaFacetoMyositis and make sure we have accounted for all the “Spots” of myositis.

• Video Chats – We have scheduled interactive video chats to entertain, build community, educ8, and advo8 for ourselves. And, we are in the final stages of planning an “Exercise and Myositis” video chat session with one of our medical committee advisors, Dr. Tao Chung.

• Social Media Outreach – As always we want to increase awareness of myositis so we have again enlisted the Thunderclap tool. This helps us to multiply our reach exponentially. We ask that our members, and their friends and family members, add their social strength by joining the campaign. The campaign link will be available on our Facebook page and website.

• Educational Outreach – The President of MSU, Jerry Williams, has been invited to speak about MSU and Myositis at Idera Pharmaceuticals Pennsylvania location on May 25th. Jerry will speak about his experience in living with Polymyositis, discuss the other forms of idiopathic inflammatory myopathies (myositis) such as Dermatomyositis, Inclusion Body Myositis, and the Juvenile forms of Myositis, in an effort to educate and promote awareness to the employees of Idera. Heather Spadaccini, a friend and often care partner for Jerry, will speak about how frightening this disease can be and some of the complications she has witnessed along the way. As this disease affects everyone around us, hearing from a friend and care partner helps others to better understand this disease. MSU collaborated with Idera on their clinical trial that is still recruiting for the experimental drug IMO-8400 for adults with Dermatomyositis.

• Fundraising – MSU operates an all-volunteer board and staff, but our programs cost money. We run three major Facebook support groups boasting over 2000 members, we have an interactive membership website full of resources and ways to connect, we offer regular video chats, we have a financial assistance program that provides funds to myositis patients in need of financial help for medical expenses, medical travel, and household expenses, and we continue to listen to our constituents to build new programs where needed. To ensure we continue to have available funds to continue our important work we ask that you consider donating at least $25 during the month of May or even setting up a recurring donation on a monthly or yearly basis. Support our mission and our work by making your contribution at UnderstandingMyositis.org/donate

For announcements during Myositis Awareness Month and all year long, please visit our Facebook page at FB.me/UnderstandingMyositis and our website, UnderstandingMyositis.org, where you will an abundance of information.

Jerry Williams
Myositis Support and Understanding Association, Inc.
302-339-3241
email us here


Source: EIN Presswire

Ayurvedic and Integrative Medicine Expert Dr. Nancy Lonsdorf to be Featured on CUTV News Radio

Dr. Nancy Lonsdorf joins CUTV News Radio to offer real solutions to our health care challenges beyond who and how we pay for it.

They call what I do ‘alternative medicine,’ but I prefer to think of it as ‘integrative.’”

— Dr. Nancy Lonsdorf

FAIRFIELD, IOWA, UNITED STATES, April 28, 2017 /EINPresswire.com/ — For decades, conventional and alternative medicine have been at odds, but Dr. Lonsdorf has found a way to seamlessly balance the disciplines.

“They call what I do ‘alternative medicine,’ but I prefer to think of it as ‘integrative,’” says Dr. Lonsdorf. “My patients seek me out for a solution without a lot of side effects, and they feel confident entrusting me with their health since I’m also trained in western medicine.”

Trained at both John Hopkins and Stanford, Dr. Lonsdorf is the former medical director of the Ayurveda Medical Center of Washington DC, where she served a wide spectrum of patients, including government officials and prominent leaders committed to feeling and looking their best, without drugs and their side-effects.

According to Dr. Lonsdorf, to solve our healthcare crisis, we need a totally new approach that puts healing the patient in the forefront. A pioneering integrative physician, Dr. Lonsdorf walks her talk, and has offered a personalized approach to creating real health from within using Ayurveda, the traditional health knowledge of India, since 1986.

“When we’re healthy, all parts of the body work together in harmony,” explains Dr. Lonsdorf. “Conventionally, doctors treat symptoms by trying to suppress them with drugs. I say, let’s find out what went wrong with your body’s natural ability to keep itself healthy. What in your diet, your lifestyle, your mind and emotions, your stressors, your relationships, your sleep habits and environment are contributing to your symptoms, and how can we turn that around to start creating health, rather than hurting it?

Ayurveda, Functional Medicine and other evidence-based and time-tested therapies help the body heal itself. In addition to these integrative approaches, Dr. Lonsdorf’s practice also offers in-depth personal coaching to help patients achieve timely, lasting and deep resolution regarding underlying issues in relationships, career, family matters and other life stressors that contribute to many chronic health conditions.

Says Dr. Lonsdorf: “This highly personalized approach creates complete inner restoration, the real basis of healing.”

CUTV News Radio will feature Dr. Nancy Lonsdorf in an interview with Jim Masters on May 2nd at 1pm EDT and with Doug Llewelyn on May 9th at 1pm EDT.

Listen to the show on BlogTalkRadio.

If you have a question for our guest, call (347) 996-3389.

For more information on Dr. Nancy Lonsdorf, visit http://www.DrNancyHealth.com

Lou Ceparano
CUTV News
(631) 850-3314
email us here


Source: EIN Presswire

Middle East and Africa Nasal Drug Delivery Market is Expected to grow at a CAGR of 8.1% by 2022

Middle East and Africa Nasal Drug Delivery Market Information, by Dosage Form, by Delivery Technologies, by Therapeutic Applications – Forecast till 2022

Key Players:Novartis AG, Pfizer, Inc., Sanofi-Aventis, Merck & Co., Inc., AptarGroup Inc., Johnson & Johnson Services, Inc., GlaxoSmithKline plc, Becton Dickson & Company ”

— Market Research Future

PUNE, MAHARASHTRA, INDIA, April 28, 2017 /EINPresswire.com/ — Market Highlights

The nasal route is increasingly being used for the delivery of drugs. The route offers many advantages over other routes such as its noninvasive nature, self-administration of the drug, reduction of pain and risk of infection associated with the injectable route. Self-administration also reduces the costs involved in the assisted administration of drugs. The route also avoids the first pass metabolism of drugs and is being considered for brain drug delivery due to its close association with the brain.

Other market driving factors of nasal drug delivery includes dosage reduction due to increased bioavailability and proportional reduction in side effects, growing efficacy of the route as drugs are absorbed easily from the nasal route and the development of advanced products such as metered dose pressurized containers which deliver a very precise dose. The growth of over the counter nasal drugs such as inhalers for common cold, and rhinitis is also driving the market since these advanced products also require nasal route of delivery. Off label use of symptomatic inhaler treatment is also an important market driver.
The market’s constraints include irritation of the nasal route and the low dose of a drug that can be delivered through other route of administration, low awareness and low penetration of healthcare services in poor parts of Africa. The market is consolidated and reflects an oligopolistic outlook with a few dominant players. This allows a premium to be charged on most products.

Request a Copy of Sample Report @ https://www.marketresearchfuture.com/sample_request/2696

Major Key Players

• Novartis AG,
• Pfizer, Inc.,
• Sanofi-Aventis,
• Merck & Co., Inc.,
• AptarGroup Inc.,
• Johnson & Johnson Services, Inc.,
• GlaxoSmithKline plc,
• Becton Dickson & Company

Intranasal drug delivery has been growing in popularity due to qualities of intranasal route of drug administration which includes its noninvasive nature that reduces pain and discomfort of drug administration. It also eliminates threat of infections associated with injectable and also enables self-administration of drug and the costs associated with assisted drug delivery. Other market driving factors for nasal drug delivery includes growth of over the counter nasal drugs such as inhalers for common cold, growing efficacy of the route due to development of drugs absorbed easily from the nasal route and the development of advanced products such as metered dose pressurized containers which delivers a very precise dose. Moreover the nasal route also avoids the first pass metabolism of drugs thereby reducing the dosage due to increased bioavailability. Dosage reduction leads to reduced costs and side effects of the drug. The nasal route is also being explored for drug delivery to the brain due to its close association with the brain. Another potential application is the delivery of protein based and drugs like interferon through the nasal route.

The restraints include higher costs of the treatment and the impact of the nasal conditions on the rate and extent of drug administration. The lack of awareness and comparative low popularity of the route along with the lower drug volume that can be administered restricts the use of this route and the market. The nasal drug delivery market reflects an oligopolistic outlook with a few dominant market players. Often there is a premium on the products and as such it is a high cost low volume market.

Test the market data and market information presented in more than 60 market data tables and figures spread over 84 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Nasal Drug Delivery Market Research Report – Forecast till 2022”.

Access Report Details @ https://www.marketresearchfuture.com/reports/nasal-drug-delivery-market-2696

Regional Analysis:

Depending on geographic region, nasal drug delivery market is segmented into following countries which includes UAE, Egypt, Saudi Arabia, Kuwait, Qatar and Oman. UAE is the largest market followed by Egypt. The Saudi Arabia market is also rising due to rising healthcare expenditure and growing per capita income of the people. Among the African nations Algeria seems to hold a huge potential. However the future market will be led by some parts of Africa due to large unmet needs and growing awareness of nasal route.

Segmentation:

Middle East and Africa nasal drug delivery market has been segmented on the basis of dosage form which comprises of drops, sprays, powder, gels and ointments. On the basis of system the market is segmented into unit dose, multi-dose and metered dose. On the basis of delivery technologies; market is segmented into spray, nebulizers and other. On the basis of therapeutic applications the market is again segmented into rhinitis, congestion, vaccinations and others.

Make an Enquiry @ https://www.marketresearchfuture.com/enquiry/2696

Brief TOC
1 Introduction
1.1 Definition
1.2 Scope of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure:
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
Continued….

Browse Related Report

Global Migraine market information, by types (Episodic and Chronic), by treatment type (Preventive and Abortive), by drug class (Triptans, Ergots, and Others) – Forecast to 2022

https://www.marketresearchfuture.com/reports/migraine-market-2381

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Akash Anand
Market Research Future
+1 646 845 9312
email us here


Source: EIN Presswire

Global Pain Management Drugs Market Analysis and Forecast 2021 By Type(Opioids, NSAIDs, Anti-Migraine, Anticonvulsants)

Orbis Research

Orbis Research

OrbisResearch.com has published new research report on "Global Pain Management Drugs Market Research Report and Forecast to 2021" to its database.

DALLAS, TEXAS, USA, April 28, 2017 /EINPresswire.com/ — A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report titled “Global Pain Management Drugs Market: Analysis By Type (Opioids, NSAIDs, Anti-Migraine, Anticonvulsants), By Application, By Region, By Country: Opportunities and Forecast (2011-2021)” aims to present the analysis of the market of pain management drugs. The global market is projected to display a robust growth represented by a CAGR of 4.96% during 2016– 2021, chiefly driven by large number of drugs in pipeline, rising number of chronically ill patients, new reforms and regulations in the consumption of medical cannabis.

Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/275225

Over the recent years, the global pain management drugs industry has been growing rapidly with the increasing demand for drugs which are used for the treatment of chronic pain conditions of neck, lower back, shoulders, post-operative pain, and pain during the sports injuries. Globally, the growth in the pain management drugs market is driven by large number of chronically ill patients, rise in global incidences of cancer and strong presence of pipeline drugs used for chronically ill conditions.

According to Azoth Analytics research report, “Global Pain Management Drugs Market: Analysis By Type (Opioids, NSAIDs, Anti-Migraine, Anticonvulsants), By Application, By Region, By Country: Opportunities and Forecast (2011-2021)” the global market is projected to display a robust growth with a CAGR of 4.96% during 2016– 2021.

Buy the report@http://www.orbisresearch.com/contact/purchase/275225

The report titled “Global Pain Management Drugs Market: Analysis By Type (Opioids, NSAIDs, Anti-Migraine, Anticonvulsants), By Application, By Region, By Country: Opportunities and Forecast (2011-2021)” has covered and analysed the potential of Global Pain Management Drugs Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global food service equipment market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report
Global Market (Actual Period: 2011-2015, Forecast Period: 2016E-2021F)
Pain Management Drugs Market
By Type of Drugs
Application Market
Drug Pipeline – By Developer, Phase, Indication and Status

Check for the discount: http://www.orbisresearch.com/contacts/discount/275225

Regional Markets – N. America, Europe, APAC, Latin America, RoW (Actual Period: 2011-2015, Forecast Period: 2016E-2021F)
Pain Management Drugs Market
By Type of Drugs

Country Analysis – US, Canada, UK, Germany, France, Japan, China, India, Brazil, Mexico (Actual Period: 2011-2015, Forecast Period: 2016E-2021F)
Pain Management Drugs Market

Other Report Highlights
Market Dynamics – Trends, Drivers, Challenges
Policy and Regulation
Company Analysis – Endo Pharmaceuticals, AstraZeneca, Novartis , Purdue Pharma, GSK, Tetra Bio Pharma, Allergen, Boehringer-Ingelheim, Sanofi,Pfizer

Customization of the Report
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Hector Costello
Orbis Research
+1 (214) 884-6817
email us here


Source: EIN Presswire

COA Compendium Paper Collects Findings from 25 Years of 340B Drug Discount Program Research

White Paper Released at 2017 Community Oncology Conference Provides Comprehensive Reviews of 340B Data and Evidence

We need to ensure that the savings from 340B go directly towards helping patients in need, not hospital profits and CEO bonuses.”

— Jeff Vacirca, CEO of NY Cancer Specialists and president of COA

WASHINGTON, DISTRICT OF COLUMBIA, UNITED STATES, April 28, 2017 /EINPresswire.com/ — A compendium released today by the Community Oncology Alliance (COA) compiles the findings of research studies, white papers, and analyses looking at the growth and impact of the 340B Drug Discount Program on the United States healthcare system over the last 25 years. The findings clearly show that 340B has grown substantially, morphing into a profit-generating program for most hospitals that is very different from the noble, original program intended to help patients in need.

Examining 25 years of data since the 340B program’s beginning in 1992, the compendium, “The 340B Drug Discount Program in Review: A Look at the Data and Evidence to Date” was released today at the 2017 Community Oncology Conference. The paper focuses on the origins of the 340B program and data on its growth, particularly in hospitals. According to a report by the Medicare Payment Advisory Commission (MedPAC) to Congress, by 2014, there were 2,140 hospitals participating in 340B. Today, approximately 45 percent of all acute care hospitals participate in the 340B program.

Read the full compendium paper "The 340B Drug Discount Program in Review: A Look at the Data and Evidence to Date."

“340B is an invaluable program for community and safety-net providers, including rural hospitals. However, for most 340B hospitals, despite providing relatively low levels of charity care, it has become a significant profit generator,” said Jeff Vacirca, MD, FACP, oncologist, CEO of NY Cancer Specialists in Long Island, NY, and president of COA. “What the data and evidence clearly show is that we need to halt the unsustainable growth of 340B in order to save it. We need to ensure that the savings from 340B go directly towards helping patients in need, not hospital profits and CEO bonuses.”

The paper compiles the latest evidence on the profits 340B hospitals make while providing low levels of the requisite charity care. The 340B program does not require that the savings on drugs be passed on to lower patients’ costs. In fact, a report by the Office of Inspector General (OIG) found that two-thirds of hospitals do not offer the reduced 340B prices to uninsured patients – the very patients 340B was designed to help. The compendium concludes that 340B has become a classic case of well-intentioned public policy causing unintended consequences.

"We have long known that 340B is a good program gone really, really bad, and the 25 years of data captured in this compendium clearly shows that,” said Ted Okon, executive director of COA. “Contrary to misleading claims by 340B hospital advocates that the program only hurts pharmaceutical companies’ bottom lines, the facts document that 340B expansion in hospitals is having an adverse impact on patient care and finances, Medicare and taxpayer budgets, and is fueling drug price increases.”

The annual Community Oncology Conference is the most comprehensive community oncology conference in the country. With more than 1,300 attendees, the conference has three distinct agenda tracks with content covering clinical, business, and advocacy topics. The 2017 theme is “Fueling the Cancer Moonshot: Innovation in Community Oncology.” The conference is currently taking place April 27-28 in National Harbor, MD, right outside of Washington, DC.

Read the full compendium The 340B Drug Discount Program in Review: A Look at the Data and Evidence to Date at http://bit.ly/340bcompendium.

###

About the Community Oncology Alliance: The Community Oncology Alliance (COA) is a non-profit organization dedicated solely to preserving and protecting access to community cancer care, where the majority of Americans with cancer are treated. COA leads community cancer clinics in navigating an increasingly challenging environment to provide efficiencies, patient advocacy, and proactive solutions to Congress and policy makers. To learn more about COA visit www.CommunityOncology.org.

Nicolas Ferreyros
Community Oncology Alliance
6466854262
email us here


Source: EIN Presswire

Global Bone Regeneration Material Market 2017 Forecast to 2022

Wiseguyreports.Com Publish New Market Research Report On-“Global Bone Regeneration Material Market 2017 Forecast to 2022”.

PUNE, INDIA, April 28, 2017 /EINPresswire.com/ —

Bone Regeneration Material Market 2017

This report studies Bone Regeneration Material in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
OSSIF
Surgical Esthetics
J Morita USA
Zimmer Biomet Holdings
Stryker Corporation
Kerr Restoratives
Septodont
Straumann
BioComp

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/1228377-global-bone-regeneration-material-market-professional-survey-report-2017

By types, the market can be split into
Xenogene Bone Materials
Partially Synthetic Materials
Synthetic Materials

By Application, the market can be split into
Surgical Orthopaedics
Bone Traumatology
Dental Surgery

By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India

Complete Report Details @ https://www.wiseguyreports.com/reports/1228377-global-bone-regeneration-material-market-professional-survey-report-2017

Table of Contents

Global Bone Regeneration Material Market Professional Survey Report 2017
1 Industry Overview of Bone Regeneration Material
1.1 Definition and Specifications of Bone Regeneration Material
1.1.1 Definition of Bone Regeneration Material
1.1.2 Specifications of Bone Regeneration Material
1.2 Classification of Bone Regeneration Material
1.2.1 Xenogene Bone Materials
1.2.2 Partially Synthetic Materials
1.2.3 Synthetic Materials
1.3 Applications of Bone Regeneration Material
1.3.1 Surgical Orthopaedics
1.3.2 Bone Traumatology
1.3.3 Dental Surgery
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India

2 Manufacturing Cost Structure Analysis of Bone Regeneration Material
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Bone Regeneration Material
2.3 Manufacturing Process Analysis of Bone Regeneration Material
2.4 Industry Chain Structure of Bone Regeneration Material

3 Technical Data and Manufacturing Plants Analysis of Bone Regeneration Material
3.1 Capacity and Commercial Production Date of Global Bone Regeneration Material Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Bone Regeneration Material Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Bone Regeneration Material Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Bone Regeneration Material Major Manufacturers in 2016
…………

8 Major Manufacturers Analysis of Bone Regeneration Material
8.1 OSSIF
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 OSSIF 2016 Bone Regeneration Material Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 OSSIF 2016 Bone Regeneration Material Business Region Distribution Analysis
8.2 Surgical Esthetics
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Surgical Esthetics 2016 Bone Regeneration Material Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Surgical Esthetics 2016 Bone Regeneration Material Business Region Distribution Analysis
8.3 J Morita USA
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 J Morita USA 2016 Bone Regeneration Material Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 J Morita USA 2016 Bone Regeneration Material Business Region Distribution Analysis
8.4 Zimmer Biomet Holdings
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
……..Continued

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1228377

Norah Trent
Wise Guy Consultants Pvt. Ltd.
+1 (339) 368 6938 (US)/+91 841 198 5042 (IND)
email us here


Source: EIN Presswire

Sports Nutrition and High Energy Supplements Market Report 2017: Glanbia Plc, Nestle, Red Bull

The major players in the Global Sports Nutrition and High Energy Supplements Market include Abbott Laboratories, Maxinutrition Ltd, PepsiCo

PUNE, INDIA, April 28, 2017 /EINPresswire.com/ — Sports Nutrition and High Energy Supplements Industry

The Global Sports Nutrition and High Energy Supplements Market is estimated to be $38 billion in 2014 and is expected to reach $80 billion by 2022, growing at a compound annual growth rate (CAGR) of 9.75% through 2022. The factors that are favoring the market growth include increase in health awareness, rise in income of the consumers and rapid urbanization. This market has potential to grow in untapped countries like India, China, Brazil and Japan. The threat of substitutes and negative publicity about the inclusion of forbidden ingredients are the challenges of the Sports Nutrition Market.

For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/222016-global-sports-nutrition-and-high-energy-supplements-market-outlook-2014-2022

The Global Sports Nutrition and High Energy Supplements Market is categorized into two broad segments: product type and geography. Based on product type, the market is segmented into sports food, sports drinks and sports supplements. By geography, the market is categorized into North America, Europe, Asia Pacific and Rest of the World. In terms of market sizes, North America is the largest consumer of sports nutrition products, followed by Europe.

The major players in the Global Sports Nutrition and High Energy Supplements Market include Abbott Laboratories, Maxinutrition Ltd, PepsiCo, The Coca-Cola Company, Glanbia Plc, Monster Beverage Corporation, Nestle, Yakult Honsha, Unilever and Red Bull.

Try Sample Report @ https://www.wiseguyreports.com/sample-request/global-sports-nutrition-and-high-energy-supplements-market-outlook-2014-2022

What our report offers:

– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 8 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements

TABLE OF CONTENT

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Research Scope
2.3 Research Methodology
2.4 Research Sources

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Sports Nutrition and High Energy Supplements Market, By Product
5.1 Sports Food
5.2 Sports Drinks
5.3 Sports Supplements

6 Global Sports Nutrition and High Energy Supplements Market, By Geography
6.1 North America
6.1.1 US
6.1.2 Canada
6.2 Europe
6.2.1 Germany
6.2.2 France
6.2.3 Italy
6.2.4 UK
6.2.5 Spain
6.3 Asia Pacific
6.3.1 Japan
6.3.2 China
6.3.3 India
6.3.4 Australia
6.3.5 New Zealand
6.3.6 Rest of Asia
6.4 Rest of the World
6.4.1 Latin America
6.4.2 Middle East
6.4.3 Africa
6.4.4 Others

7 Key Developments
7.1 Agreements, Partnerships, Collaborations and Joint Ventures
7.2 Acquisitions & Mergers
7.3 New Product Launch
7.4 Expansions
7.5 Other Key Strategies

8 Company Profiling
8.1 Abbott Laboratories
8.2 Maxinutrition Ltd
8.3 PepsiCo
8.4 The Coca-Cola Company
8.5 Glanbia Plc
8.6 Monster Beverage Corporation
8.7 Nestle
8.8 Yakult Honsha
8.9 Unilever
8.10 Red Bull

Buy this report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=222016

About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global Migraine Drugs Market 2017 Share, Trend, Segmentation and Forecast To 2022

Wiseguyreports.Com Publish New Market Research Report On-“Global Migraine Drugs Market 2017 Share, Trend, Segmentation and Forecast To 2022”.

PUNE, INDIA, April 28, 2017 /EINPresswire.com/ —

Migraine Drugs Market 2017

Global Migraine Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Allergan
Merck
Pfizer
Teva
Pfizer
Johnson & Johnson
Endo International
GlaxoSmithKline
Impax
Abbott
Bayer
Eli Lilly
Ethypharm
Kowa Pharmaceuticals America
Winston Pharmaceuticals
AstraZeneca

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/1227988-global-migraine-drugs-market-research-report-2017

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Migraine Drugs in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Sumatriptan
Zolmitriptan
Rizatriptan
Other Drug

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Migraine Drugs for each application, including
Hospitals
Clinics
Household Use
Others

Complete Report Details @ https://www.wiseguyreports.com/reports/1227988-global-migraine-drugs-market-research-report-2017

Table of Contents

Global Migraine Drugs Market Research Report 2017
1 Migraine Drugs Market Overview
1.1 Product Overview and Scope of Migraine Drugs
1.2 Migraine Drugs Segment by Type (Product Category)
1.2.1 Global Migraine Drugs Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
1.2.2 Global Migraine Drugs Production Market Share by Type (Product Category) in 2016
1.2.3 Sumatriptan
1.2.4 Zolmitriptan
1.2.5 Rizatriptan
1.2.6 Other Drug
1.3 Global Migraine Drugs Segment by Application
1.3.1 Migraine Drugs Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Household Use
1.3.5 Others
1.4 Global Migraine Drugs Market by Region (2012-2022)
1.4.1 Global Migraine Drugs Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Migraine Drugs (2012-2022)
1.5.1 Global Migraine Drugs Revenue Status and Outlook (2012-2022)
1.5.2 Global Migraine Drugs Capacity, Production Status and Outlook (2012-2022)

2 Global Migraine Drugs Market Competition by Manufacturers
2.1 Global Migraine Drugs Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Migraine Drugs Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Migraine Drugs Production and Share by Manufacturers (2012-2017)
2.2 Global Migraine Drugs Revenue and Share by Manufacturers (2012-2017)
2.3 Global Migraine Drugs Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Migraine Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Migraine Drugs Market Competitive Situation and Trends
2.5.1 Migraine Drugs Market Concentration Rate
2.5.2 Migraine Drugs Market Share of Top 3 and Top 5 Manufacturers
…………

7 Global Migraine Drugs Manufacturers Profiles/Analysis
7.1 Allergan
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Migraine Drugs Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Allergan Migraine Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Merck
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Migraine Drugs Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Merck Migraine Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Pfizer
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Migraine Drugs Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Pfizer Migraine Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 Teva
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Migraine Drugs Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
……..Continued

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1227988

Norah Trent
Wise Guy Consultants Pvt. Ltd.
+1 (339) 368 6938 (US)/+91 841 198 5042 (IND)
email us here


Source: EIN Presswire

Global Egg Protein Industry Share,Trends,Applications,Segmentation and Forecast to 2022

WiseGuyReports.Com Publish a New Market Research Report On – “Global Egg Protein Industry Share,Trends,Applications,Segmentation and Forecast to 2022”.

PUNE, INDIA, April 28, 2017 /EINPresswire.com/ —

"Egg proteins include Egg white powder, egg yolk powder and whole egg powder.
Talking about the egg white and yolk proteins, it can be said that one large egg contains about 6.5 grams of protein, out of which egg white protein content is about 3.6 grams."

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/1228901-global-egg-protein-market-by-manufacturers-countries-type-and-application-forecast

For more information or any query mail at sales@wiseguyreports.com

Scope of the Report:

This report focuses on the Egg Protein in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Avangardco
Sanovo
IGRECA
Interovo
Bouwhuis Enthoven
BNLfood
Post Holdings
Eurovo Group
Rose Acre Farms
VH group
Wulro
A.G. Foods
Farm Pride
GF Ovodry
Adriaan Goede
SOVIMO HELLAS
Rembrandt
DEB EL FOOD
Lodewijckx Group
Kewpie
Dalian Lvxue
Jinlin Houde
Kangde Biological
Dalian Hanovo Foods
Etam Biological Polytron Technologies

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Whole Egg Powder
Egg White Powder
Egg Yolk Powder

Market Segment by Applications, can be divided into
Bakery
Meat Product
Ice Cream
Other

Complete Report Details@ https://www.wiseguyreports.com/reports/1228901-global-egg-protein-market-by-manufacturers-countries-type-and-application-forecast

There are 15 Chapters to deeply display the global Egg Protein market.

Chapter 1, to describe Egg Protein Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Egg Protein, with sales, revenue, and price of Egg Protein, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Egg Protein, for each region, from 2012 to 2017;

Continue…….

Table Of Contents – Major Key Points

1 Market Overview
1.1 Egg Protein Introduction
1.2 Market Analysis by Type
1.2.1 Whole Egg Powder
1.2.2 Egg White Powder
1.2.3 Egg Yolk Powder
1.3 Market Analysis by Applications
1.3.1 Bakery
1.3.2 Meat Product
1.3.3 Ice Cream
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA Market States and Outlook (2012-2022)
1.4.1.2 Canada Market States and Outlook (2012-2022)
1.4.1.3 Mexico Market States and Outlook (2012-2022)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2012-2022)
1.4.2.2 France Market States and Outlook (2012-2022)
1.4.2.3 UK Market States and Outlook (2012-2022)
1.4.2.4 Russia Market States and Outlook (2012-2022)
1.4.2.5 Italy Market States and Outlook (2012-2022)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2012-2022)
1.4.3.2 Japan Market States and Outlook (2012-2022)
1.4.3.3 Korea Market States and Outlook (2012-2022)
1.4.3.4 India Market States and Outlook (2012-2022)
1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2012-2022)
1.4.4.2 Egypt Market States and Outlook (2012-2022)
1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
1.4.4.4 South Africa Market States and Outlook (2012-2022)
1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force

2 Manufacturers Profiles
2.1 Avangardco
2.1.1 Business Overview
2.1.2 Egg Protein Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Avangardco Egg Protein Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Sanovo
2.2.1 Business Overview
2.2.2 Egg Protein Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Sanovo Egg Protein Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 IGRECA
2.3.1 Business Overview
2.3.2 Egg Protein Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 IGRECA Egg Protein Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Interovo
2.4.1 Business Overview
2.4.2 Egg Protein Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Interovo Egg Protein Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Bouwhuis Enthoven
2.5.1 Business Overview
2.5.2 Egg Protein Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Bouwhuis Enthoven Egg Protein Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 BNLfood
2.6.1 Business Overview
2.6.2 Egg Protein Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 BNLfood Egg Protein Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Post Holdings
2.7.1 Business Overview
2.7.2 Egg Protein Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Post Holdings Egg Protein Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Eurovo Group
2.8.1 Business Overview
2.8.2 Egg Protein Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Eurovo Group Egg Protein Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Rose Acre Farms

Continued…….

For more information or any query mail at sales@wiseguyreports.com

Buy 1-User PDF @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1228901

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of rmaket research reports under these categories and sub-categories.

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Micronutrients Market 2017 Global Industry Sales, Supply, Consumption Analysis and Forecasts to 2022

Wiseguyreports.Com Publish New Market Research Report On-“Micronutrients Market 2017 Global Industry Sales, Supply, Consumption Analysis and Forecasts to 2022”.

PUNE, INDIA, April 28, 2017 /EINPresswire.com/ —

Micronutrients Market 2017

This report studies Micronutrients in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
BASF
Akzo Nobel
Yara International
Haifa
Agrium
Haifa
Stoller
Mosaic
JR Simplot
Nulex
Sapec SA
Wolf Trax
Dayal Group
Sam Hprp
Frit Industries
Valagro
ATP Nutrition
Kronos Micronutrients
Sun Agrigenetics
QC Corporation
Coromandel International
Microfeed
Sinofert Holding
Jinpai Fertilier
Hui Yi Chemical
Wintong Chemicals

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/1227987-global-micronutrients-market-professional-survey-report-2017

By types, the market can be split into
Mixed Fertilizers
Sprays

By Application, the market can be split into
Soil fetilizer
Foliar fetilizer
Seed Treatment
Hydroponics
Others

By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India

Complete Report Details @ https://www.wiseguyreports.com/reports/1227987-global-micronutrients-market-professional-survey-report-2017

Table of Contents
Global Micronutrients Market Professional Survey Report 2017
1 Industry Overview of Micronutrients
1.1 Definition and Specifications of Micronutrients
1.1.1 Definition of Micronutrients
1.1.2 Specifications of Micronutrients
1.2 Classification of Micronutrients
1.2.1 Mixed Fertilizers
1.2.2 Sprays
1.3 Applications of Micronutrients
1.3.1 Soil fetilizer
1.3.2 Foliar fetilizer
1.3.3 Seed Treatment
1.3.4 Hydroponics
1.3.5 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India

2 Manufacturing Cost Structure Analysis of Micronutrients
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Micronutrients
2.3 Manufacturing Process Analysis of Micronutrients
2.4 Industry Chain Structure of Micronutrients

3 Technical Data and Manufacturing Plants Analysis of Micronutrients
3.1 Capacity and Commercial Production Date of Global Micronutrients Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Micronutrients Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Micronutrients Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Micronutrients Major Manufacturers in 2016
…………

8 Major Manufacturers Analysis of Micronutrients
8.1 BASF
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 BASF 2016 Micronutrients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 BASF 2016 Micronutrients Business Region Distribution Analysis
8.2 Akzo Nobel
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Akzo Nobel 2016 Micronutrients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Akzo Nobel 2016 Micronutrients Business Region Distribution Analysis
8.3 Yara International
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Yara International 2016 Micronutrients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Yara International 2016 Micronutrients Business Region Distribution Analysis
8.4 Haifa
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
……..Continued

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1227987

Norah Trent
Wise Guy Consultants Pvt. Ltd.
+1 (339) 368 6938 (US)/+91 841 198 5042 (IND)
email us here


Source: EIN Presswire